Stock Analiz

Astrazeneca PLC (AZN) stock forecast and price target

Price $184.45 · data as of November 13, 2026

12-month price target

Average target$208.07
Upside / downside+12.8%
Analysts12
ConsensusBuy
Low $158.00Average $208.07High $240.00

Gold marker: average target · white marker: today’s price ($184.45)

Analyst ratings

Strong buy 2Buy 7Hold 2Sell 1Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$10.12+121.0%$63.4B
Next fiscal year
ends December 31, 2027
$11.32+11.8%$67.4B
Next quarter
ends December 31, 2026
$1.74—$16.6B

Consensus of the analysts covering Astrazeneca, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.

Our model vs. Wall Street

Analysts see 12.8% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Astrazeneca’s intrinsic value about 38% below today’s market value, and it scores 2.8 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the Astrazeneca stock price target?

The average 12-month target from 12 analysts is $208.07, 12.8% above the current price of $184.45 Targets range from $158.00 to $240.00.

Is Astrazeneca a buy according to analysts?

The consensus rating is “Buy” (2 strong buy, 7 buy, 2 hold, 1 sell). Ratings are opinions, not guarantees; this is not investment advice.

How much is Astrazeneca expected to earn?

Analysts expect EPS of $10.12 for the fiscal year ending December 31, 2026 and $11.32 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.